https://www.selleckchem.com/pr....oducts/Mizoribine.ht
Non-tuberculous mycobacterial pulmonary disease is on the rise globally. It is often missed, and causes significant morbidity and even mortality. Here, members of a clinical research network and a patient support group discuss some of the current key issues in NTM management. In addition to the need for research into epidemiology, immunology and treatment, we recommend greater use of patient and clinician networks to (i) educate primary and secondary care clinicians to develop a high index of suspicion when investigating and treating
Like
Comment
Share
